At a glance
ClinicalIndex Comparison RecordN/ACompleted· 6,000 enrolled
Drug / intervention
Low intensity +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Targeted Adherence Intervention to Reach Glycemic Control With Insulin Therapy for Patients With Diabetes (TARGIT-DM)
In Brief
A clinical study evaluating Low intensity, Moderate intensity, and 1 other intervention for Diabetes. Completed, enrolled 6,000 participants across 1 site.
Detailed Summary
The purpose of this study is to evaluate three pharmacist-outreach strategies for improving adherence to insulin among individuals with diabetes. The three approaches are equivalently-priced but vary by degree of targeting and intervention intensity.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
CollaboratorsHorizon Blue Cross Blue Shield of New Jersey
Timeline
N/ACompletedFinished
2017201820192020202120222023202420252026
Enrollment StartJul 2016
First PostedJul 2016
Primary CompletionDec 2017
Study CompletionFeb 2018
TodayJul 2026
First PostedJul 27, 2016
Enrollment StartJul 1, 2016
Primary CompletionDec 30, 2017
Study CompletionFeb 10, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.9 years ago
Interventions
Low intensityother
Low intensity telepharmacy outreach
Moderate intensityother
Moderate intensity telepharmacy outreach
High intensityother
High intensity telepharmacy outreach